CD4 and non-small cell lung carcinoma: demonstrated that high levels of CD8 (+) T lymphocytes and CD4 (+) T lymphocytes were important indicators for evaluating the prognosis of NSCLC patients, and the cooperation between these cell populations may produce more effective anti-tumor responses than any individual population (40).